Eversheds Sutherland advises Humanwell Healthcare Group on the Acquisition of the assets of Paion AG and Paion Deutschland GmbH including shares in Paion Holdings UK
March 13, 2024
Humanwell Healthcare (Group) Co. Ltd. is a leading Chinese listed pharmaceutical company mainly engaged in the development, manufacture and distribution of drugs in the fields of anaesthesia and analgesics, gynaecological diseases, central nervous system, dermatology and respiratory diseases as well as other drugs used in hospitals.
Humanwell has more than 520 approved drugs worldwide and 350 drug candidates in the pipeline. In 2022, Humanwell generated sales of USD 3.4 billion and a net profit of USD 0.38 billion. Humanwell distributes its products mainly in China, Africa and the USA and exports its products to more than 50 countries.
"The sale of PAION to Humanwell is a success for the insolvency process, as the majority of jobs have been saved and the full and comprehensive continuation of business operations has been secured. I am confident that PAION will be positioned for the future under the umbrella of Humanwell. This result is due to the committed and professional cooperation with managing director Tilmann Bur and the other parties involved in the proceedings," says Dr. Mark Boddenberg, who is accompanying the proceedings as the court-appointed insolvency administrator.
The Eversheds Sutherland team was led by Corporate M&A Partner Hui Zhao, Commercial Partner Christian Ostermöller and Banking & Finance Partner Daniel Ehret. Further team members were Martin Gliewe and Sabrina Rübsam (both Labour Law), Rebecca Flachs Nobrega and Bohan Wan (both Corporate M&A).
Latest Insights
Latest News
- client newsEversheds Sutherland Advises Horace Mann on Transactions with Medical Mutual of Ohio
- client newsAdvising Johnson Matthey on completion of the sale of its Catalyst Technologies business to Honeywell
- firm newsEversheds Sutherland Continues California Growth with Addition of Former US National Security Prosecutor S. Waqar Hasib
- client newsEversheds Sutherland Advises Teucrium As Sponsor for Y’all Street Physical Gold and Silver ETFs, Trading on the Nasdaq with Texas Precious Metals as Sole Custodian
Latest Events
- virtual | September 10, 2026UAE - Employment law in the Dubai International Financial Centre
- in-person | September 10, 2026Managing AI use in the workplace: what every UK HR team needs to know
- in-person | September 17, 2026Basic foundations of US employment law
- in-person | September 23, 20262026 BDC Roundtable
legal updates
July 27, 2026
EU adopts its 21st sanctions package against Russia and Belarus
legal updates
July 24, 2026
Global payment matters - July 2026
legal updates
July 23, 2026
Wiretap claims arising from cross-border transfers of website user data
legal updates
July 23, 2026
AI Governance Bill: Malaysia’s Next Step Towards the First AI Rulebook
client news
July 27, 2026
Eversheds Sutherland Advises Horace Mann on Transactions with Medical Mutua...
client news
July 24, 2026
Advising Johnson Matthey on completion of the sale of its Catalyst Technolo...
firm news
July 20, 2026
Eversheds Sutherland Continues California Growth with Addition of Former US...
client news
July 20, 2026
Eversheds Sutherland Advises Teucrium As Sponsor for Y’all Street Physical ...
virtual
UAE - Employment law in the Dubai International Financial Centre
September 10, 2026
9.30am - 1.30pm (GMT)
Virtual
in-person
Managing AI use in the workplace: what every UK HR team needs to know
September 10, 2026
9.30am - 1.00pm (BST)
London, United Kingdom
in-person
Basic foundations of US employment law
September 17, 2026
9.30am - 4.30pm (GMT)
London, United Kingdom
in-person
2026 BDC Roundtable
September 23, 2026
Washington DC, United States